Related references
Note: Only part of the references are listed.Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration
Inho Choi et al.
ANGIOGENESIS (2013)
Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy
M. I. Nawaz et al.
EXPERIMENTAL EYE RESEARCH (2013)
Alternative C-Terminal Helix Orientation Alters Chemokine Function STRUCTURE OF THE ANTI-ANGIOGENIC CHEMOKINE, CXCL4L1
Je-Hung Kuo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The CXCL12-CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis
Wei Zhuo et al.
CLINICAL CANCER RESEARCH (2012)
Interaction of tumor cells and lymphatic vessels in cancer progression
A. Alitalo et al.
ONCOGENE (2012)
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3
Sofie Struyf et al.
BLOOD (2011)
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer
Jo Vandercappellen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Molecular pathways of platelet factor 4/CXCL4 signaling
Brigitte Kasper et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
Chemokines as mediators of tumor angiogenesis and neovascularization
Ellen C. Keeley et al.
EXPERIMENTAL CELL RESEARCH (2011)
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes
Anna Korniejewska et al.
IMMUNOLOGY (2011)
CXCR3 ligands: redundant, collaborative and antagonistic functions
Joanna R. Groom et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Functions and regulation of the 70 kDa ribosomal S6 kinases
Tim R. Fenton et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
CXCL4L1 inhibits angiogenesis and induces undirected endothelial cell migration without affecting endothelial cell proliferation and monocyte recruitment
A. Sarabi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Functional divergence between 2 chemokines is conferred by single amino acid change
Alexandre Dubrac et al.
BLOOD (2010)
Evidence for PI3K-dependent CXCR3 agonist-induced degranulation of human cord blood-derived mast cells
Ian Willox et al.
MOLECULAR IMMUNOLOGY (2010)
Citrullination of CXCL12 Differentially Reduces CXCR4 and CXCR7 Binding with Loss of Inflammatory and Anti-HIV-1 Activity via CXCR4
Sofie Struyf et al.
JOURNAL OF IMMUNOLOGY (2009)
Understanding the immunoangiostatic CXC chemokine network
Maria Luisa Balestrieri et al.
CARDIOVASCULAR RESEARCH (2008)
CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulation
Hernan Roca et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3
Anja Mueller et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis
Sofie Struyf et al.
CANCER RESEARCH (2007)
Identification of novel drug targets for Angiostatic cancer therapy; It takes two to tango
Victor L. J. L. Thijssen et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways
Syed Shahabuddin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells
ED Feldman et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Interaction of chemokines and glycosaminoglycans: A new twist in the regulation of chemokine function with opportunities for therapeutic intervention
Z Johnson et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase
B Kasper et al.
BLOOD (2004)
The chemokine system - a major regulator of angiogenesis in health and disease
MM Rosenkilde et al.
APMIS (2004)
Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis
S Struyf et al.
CIRCULATION RESEARCH (2004)
CXCR3-mediated chernotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase
MJ Smit et al.
BLOOD (2003)
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4
L Lasagni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells
JH Hwang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway
E Sulpice et al.
BLOOD (2002)
Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties
P Proost et al.
BLOOD (2001)
Signal transduction by the chemokine receptor CXCR3 - Activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes
A Bonacchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
M Hidalgo et al.
ONCOGENE (2000)
Share Paper
